Marta Brambilla

Marta Brambilla

Auto-generated profile, based on publicly available information

Marta Brambilla

Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2006 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
NMNorma Maugeri
Norma Maugeri
MBM. Brambilla
M. Brambilla
MCM. Camera
M. Camera
ACA. Carbone
A. Carbone
ETElena Tremoli
Elena Tremoli
CCChiara Cerletti
Chiara Cerletti
Summary. Background: Blood-borne tissue factor (TF) plays a crucial role in thrombogenesis. Aim: To study whether polymorphonuclear leukocytes (PMN) are a source of TF. Methods and Results: Human PMN were carefully separated from other blood cells and stimulated for 3 min with purified P-selectin or the chemotactic peptide formyl-MetLeuPhe (fMLP): they expressed both TF procoagulant activity, as identified by specific TF MoAb and inactivated factor VIIa blockade; and TF:Ag (four to six times), as shown by flow-cytometry and immunocytochemistry. About 40% of permeabilized PMN, both resting and stimulated, contained TF:Ag, indicating that stimulation only modifies the location of TF:Ag within PMN. By real time-polymerase chain reaction (RT-PCR), a very low amount of TF mRNA was detectable in resting PMN, but a 3- to 5-fold increase was observed after 1-h stimulation with P-selectin or fMLP, respectively. Conclusions: These findings suggest that TF is not constitutively expressed in peripheral PMN, but can be up-regulated and produced upon stimulation and specific gene transcription, as for instance during contact with activated platelets or endothelium. The stored TF is rapidly expressed in vitro as a functional molecule on the surface of activated PMN. The availability of PMN TF supports the relevance of inflammatory cells and their interaction with platelets for fibrin deposition and thrombus formation.

14 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
NCNicola Cosentino
Nicola Cosentino
JCjeness campodonico
jeness campodonico
VMValentina Milazzo
Valentina Milazzo
MMMonica De Metrio
Monica De Metrio
MBMarta Brambilla
Marta Brambilla
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
Vitamin D deficiency is a prevalent condition, occurring in about 30–50% of the population, observed across all ethnicities and among all age groups. Besides the established role of vitamin D in calcium homeostasis, its deficiency is emerging as a new risk factor for cardiovascular disease (CVD). In particular, several epidemiological and clinical studies have reported a close association between low vitamin D levels and major CVDs, such as coronary artery disease, heart failure, and atrial fibrillation. Moreover, in all these clinical settings, vitamin deficiency seems to predispose to increased morbidity, mortality, and recurrent cardiovascular events. Despite this growing evidence, interventional trials with supplementation of vitamin D in patients at risk of or with established CVD are still controversial. In this review, we aimed to summarize the currently available evidence supporting the link between vitamin D deficiency and major CVDs in terms of its prevalence, clinical relevance, prognostic impact, and potential therapeutic implications.

1 July 2004 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Silvia Stella BarbieriSilvia Stella Barbieri
Silvia Stella Barbieri
VCViviana Cavalca
Viviana Cavalca
SESonia Eligini
Sonia Eligini
MBMarta Brambilla
Marta Brambilla
ACAlessia Caiani
Alessia Caiani
SCSusanna Colli
Susanna Colli

1 September 2003 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MCMarina Camera
Marina Camera
MFMarta Frigerio
Marta Frigerio
VTVincenzo Toschi
Vincenzo Toschi
MBMarta Brambilla
Marta Brambilla
FRFrancesca Rossi
Francesca Rossi
ETElena Tremoli
Elena Tremoli
Objective— Tissue factor (TF) is the main activator of the coagulation cascade occurring in physiologic and pathologic conditions. Recent data suggest that human platelets might contain TF that is possibly derived from leukocytes. In this study, we investigated whether intraplatelet TF can be exposed on the membrane by platelet agonists. The modulation of this process by antiplatelet drugs has been evaluated as well. Methods and Results— Flow cytometric analysis of unstimulated platelets showed a small amount of membrane-associated immunoreactive TF (irTF) in whole blood, platelet-rich plasma, and washed platelets isolated from healthy subjects. ADP, thrombin receptor-activating peptide, and epinephrine significantly increased functionally active, membrane-associated irTF. ADP induced irTF exposure in a concentration- and time-dependent fashion. Agonist-induced irTF expression was completely inhibited by iloprost but not by aspirin. Interestingly, glycoprotein IIb/IIIa antagonists did not inhibit but rather potentiated the stimulatory effect of ADP on platelet irTF expression. Real-time polymerase chain reaction experiments showed detectable amounts of TF mRNA in unstimulated platelets. Conclusions— These findings indicate that platelet agonists and antiplatelet drugs might modulate platelet-associated irTF expression. Regulated TF expression establishes the potential for a previously unrecognized role for platelets in sustaining thrombus formation and growth via coagulation-mediated mechanisms.

1 September 2007 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
APAlessandro Parolari
Alessandro Parolari
MCMarina Camera
Marina Camera
FAFrancesco Alamanni
Francesco Alamanni
MNMoreno Naliato
Moreno Naliato
GPGian Luca Polvani
Gian Luca Polvani
ETElena Tremoli
Elena Tremoli

1 May 2008 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MBMarta Brambilla
Marta Brambilla
MCMarina Camera
Marina Camera
DCDeborah Colnago
Deborah Colnago
Giancarlo MarenziGiancarlo Marenzi
Giancarlo Marenzi
MMMonica De Metrio
Monica De Metrio
ETElena Tremoli
Elena Tremoli
Objective— Activated platelets and circulating platelet-leukocyte aggregates (PLA) are significantly higher in patients with unstable angina than in those with stable angina (SA). Platelets from healthy subjects express TF on activation. The aim of this study was to investigate the expression of TF in PLA, in platelets, and in monocytes of acute coronary syndrome (ACS) patients compared to SA patients and healthy subjects (Controls). Methods and Results— We enrolled 26 consecutive patients with ACS, 29 patients with SA, and 25 Controls. A significantly greater number of total and TF positive platelet-monocyte aggregates was found by flow cytometry in blood of ACS patients than in either SA patients (3-fold) or Controls (5-fold). ACS patients also had a significantly higher amount of TF-positive platelets than SA or Controls (>3-fold) and significantly higher thrombin generation capacity. TF mRNA expression in platelets was significantly higher in ACS patients than in SA or Controls. Conclusions— In ACS patients the greater expression of TF in platelets and PLA strengthens the link between platelet activation, blood coagulation, and thrombus formation and may further contribute to the hypercoagulability associated with the disease.